Therapy Program Improves Teens' Diabetes, Depression

This article originally appeared here.
Share this content:
Therapy Program Improves Teens' Diabetes, Depression
Therapy Program Improves Teens' Diabetes, Depression

WEDNESDAY, June 3, 2015 (HealthDay News) -- The evidence-based family therapy program Behavioral Family Systems Therapy for Diabetes (BFST-D) improves both diabetes health outcomes and depressive symptoms among adolescents with type 1 diabetes, according to a study published online May 26 in Diabetes Care.

Andrew R. Riley, Ph.D., from the Oregon Health & Science University in Portland, and colleagues randomized adolescents with depressive symptoms and type 1 diabetes in suboptimal glycemic control (HbA1c ≥9 percent [75 mmol/mol]) to participate in BFST-D either via Internet videoconferencing or in person. Given no significant differences between the groups in the randomized controlled trial, groups were collapsed into a within-group prepost design for secondary analyses.

The researchers found that there were significant improvements in glycemic control, depressive symptoms, and family functioning from pre- to post-treatment. Within-subject mediation analysis demonstrated that improvements in depressive symptoms were partially mediated by improvements in parent-youth conflict. Yet family process changes did not mediate diabetes health outcomes.

"In addition to improving treatment adherence and glycemic control, BFST-D has collateral benefits on depressive symptoms," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »